Press Releases

Results 391-400 of 426

Actinium to List Common Stock on NYSE MKT

Mar 24, 2014

Actinium Announces Introduction of the New Lot of Lintuzumab into the Clinic

Mar 24, 2014

Actinium to Present at 2nd Annual Sachs Cancer Bio Partnering & Investor Forum

Mar 13, 2014

Actinium Files Annual Report on Form 10-K for the Year Ended December 31, 2013

Mar 5, 2014

Actinium to Present at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference

Feb 26, 2014

Actinium to Host Advisory Meeting at the 2014 ASBMT and CIBMTR Conference

Feb 26, 2014

Actinium Presenting at the 16th Annual BIO CEO & Investor Conference Today at 1:30 pm ET

Feb 11, 2014

Actinium to Present at the 16th Annual BIO CEO & Investor Conference

Feb 5, 2014

Actinium Engages Goodwin Biotechnology to Supply Iomab™-B for Its Phase 3 Clinical Study

Jan 29, 2014

Actinium Pharmaceuticals Announces Engagement of MissionIR Investor Relations Services

Jan 15, 2014